Description
CEA Fast Test Kit (Immunofluorescence Assay)
The CEA Fast Test Kit is a quantitative immunofluorescence assay for the detection of carcinoembryonic antigen (CEA) in serum or plasma. It is mainly used to monitor colorectal cancer treatment, assess recurrence, and support clinical staging. While not suitable for cancer screening or early detection, it plays an important role in follow-up care.
Key Advantages
- Rapid Results: Delivers quantitative CEA levels in just 15 minutes
- Monitoring Tool: Useful for evaluating colorectal carcinoma treatment response
- Metastasis Assessment: Supports staging and recurrence detection
- Sample Compatibility: Suitable for serum and plasma samples
- Stable Storage: 4–30°C with 24-month shelf life
About CEA
Carcinoembryonic antigen (CEA) is a glycoprotein produced during fetal development, typically undetectable in healthy adults. Elevated CEA levels may indicate tumor activity, particularly in colorectal cancer, but can also rise due to benign conditions or smoking. CEA testing is not intended for early cancer diagnosis but is valuable in monitoring disease progression and treatment outcomes.
Specifications
| Parameter | Details |
|---|---|
| Test Item | CEA |
| Sample Type | Serum, Plasma |
| Detection Method | Immunofluorescence Assay |
| Detection Range | 2.0–500.0 ng/mL |
| Cut-off Value | 4.7 ng/mL |
| Test Time | 15 Minutes |
| Storage Conditions | 4–30°C |
| Shelf Life | 24 Months |
Compatible Devices
- Getein 1100 Immunofluorescence Quantitative Analyzer
Clinical Applications
- Monitoring of colorectal cancer treatment and recurrence
- Staging and metastasis assessment in colorectal carcinoma
- Post-surgical follow-up for colorectal cancer patients
